Werewolf Therapeutics, Inc. · NASDAQ:HOWL
Ra Capital Management, L.P. sold 448,836 Werewolf Therapeutics, Inc. shares (Form 4)
Traded Jun 12 to Jun 16, 2026 · Filed Jun 16, 2026
From Jun 12 to Jun 16, 2026, Ra Capital Management, L.P. (10% owner) sold 448,836 Werewolf Therapeutics, Inc. shares at an average US$0.39 for US$174K, leaving 331,414 shares. Filed Jun 16, 2026 (Form 4).
- Sold
- 448,836 shares
- Price
- US$0.39 average (US$0.37 to US$0.40)
- Value
- US$174K
- Holding after
- 331,414 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Common Stock | Sale | 159,119 | US$0.40 | 4,917,566 | Indirect |
| Jun 12, 2026 | Common Stock | Sale | 11,322 | US$0.40 | 349,907 | Indirect |
| Jun 15, 2026 | Common Stock | Sale | 120,216 | US$0.39 | 4,797,350 | Indirect |
| Jun 15, 2026 | Common Stock | Sale | 8,554 | US$0.39 | 341,353 | Indirect |
| Jun 16, 2026 | Common Stock | Sale | 139,686 | US$0.37 | 4,657,664 | Indirect |
| Jun 16, 2026 | Common Stock | Sale | 9,939 | US$0.37 | 331,414 | Indirect |
Source
Related
- Werewolf Therapeutics, Inc.
- Ra Capital Management, L.P.
- Werewolf Therapeutics, Inc. shareholders
- Form 4 · Ra Capital Management, L.P. · Jun 22, 2026
- Form 4 · Ra Capital Management, L.P. · May 12, 2026
- Schedule 13G · Moll Peter · Sep 21, 2026
- Form 4 · Luke Evnin · Jul 8, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jul 2, 2026
- Form 4 · Luke Evnin · Jun 29, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 26, 2026